Skip to main content

Advertisement

Table 1 Baseline characteristics of patients with isolated pulmonary Candida spp. colonization (cohort 1)

From: Antifungal therapy in patients with pulmonary Candida spp. colonization may have no beneficial effects

  Antifungal therapy (n = 102) No antifungal therapy (n = 220) p value
Age (years) 69 (57; 76) 70 (58/78) 0.354
Sex male, n (%) 83 (81.4) 162 (73.6) 0.16
Discipline, n (%)    
 Thoracic and cardiovascular surgery 52 (50.1) 90 (40.9) 0.093
 General and visceral surgery 12 (11.8) 33 (15.0) 0.493
 Trauma surgery 9 (8.8) 29 (13.2) 0.353
 Vascular surgery 12 (11.8) 25 (11.4) 1
 Urology 3 (2.9) 1 (0.5) 0.096
 Otolaryngology 0 (0) 5 (2.3) 0.183
 Pneumology 3 (2.9) 4 (1.8) 0.683
 Oral and maxillofacial surgery 0 (0) 4 (1.8) 0.311
 Neurosurgery 3 (2.9) 20 (9.1) 0.061
 Others 8 (7.8) 9 (4.1) 0.184
Cancer, n (%) 14 (13.7) 42 (19.1) 0.271
Permanent pacemaker, n (%) 15 (14.7) 17 (7.7) 0.071
SAPS II 47 (39; 55) 40 (30; 48) <0.001
SOFA score 7 (5; 10) 4.5 (2; 8) <0.001
 Lung 2 (1; 2) 1 (1; 2) 0.437
 Thrombocytes 1 (0; 2) 0 (0; 2) 0.015
 Liver 0 (0; 2) 0 (0; 0) <0.001
 Cardiovascular 3 (0; 4) 0 (0; 3) 0.001
 Renal 1 (0; 2) 0 (0; 2) 0.017
Pre-existing pneumonia before enrollment, n (%) 58 (56.9) 89 (40.5) 0.008
  1. Data are presented as median (25 %; 75 % quartile)
  2. SAPS II Simplified Acute Physiology Score II, SOFA Sequential Organ Failure Assessment